Phibro Animal Health (PAHC) Inventory Turnover Ratio, from fourth quarter 2026 to fourth quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Phibro Animal Health Corporation  (NASDAQ: PAHC)
 

Phibro Animal Health Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Phibro Animal Health's inventory turnover ratio, the ratio that measures Phibro Animal Health's ability to manage its supply chain, sequentially decreased to 2.02 in the fourth quarter 2026, which does not come as a surprise, as the Phibro Animal Health continue to experience headwinds, which also impact its supply chain. Phibro Animal Health's average inventory processing period in the Jun 30 2026 quarter, has increased to 181 days, from 171 days, in the Mar 31 2026 quarter.

Within Healthcare sector 202 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1396 in the third quarter 2026, to 1508.

PAHC Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Phibro Animal Health Corporation Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PAHC Inventory Turnover Ratio (Jun 30 2026)
IV. Quarter		 (Mar 31 2026)
III. Quarter		 (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter		 (Jun 30 2025)
IV. Quarter
Y / Y Inventory Growth 20.35 % 20.36 % 67.13 % 73.09 % 67.13 %
Y / Y Cost of Sales Growth -2.36 % 5.65 % 16.21 % 37.9 % 43.68 %
Inventory Turnover Ratio (TTM) 2.02 2.13 2.2 2.36 2.5
PAHC's Total Ranking # 1508 # 1396 # 283 # 1279 # 1279
Average inventory processing period 181 172 166 154 146
Seq. Inventory Growth -0.89 % 21.44 % -5.8 % 6.15 % -0.88 %
Seq. Cost of Sales Growth 2.08 % 6.64 % -1.23 % -9.19 % 10.45 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 60
Healthcare Sector # 203
Overall Market # 1508

Inventory Turnover Ratio Statistics
High Average Low
3.64 2.85 2.02
(Mar 31 2015)   (Jun 30 2026)



PAHC Company Profile >> Back to PAHC Efficiency Comparisons >> Compare PAHC Inventory Turnover Ratio to its Competitors

Financial Statements
Phibro Animal Health's Inventories $ 535 Millions Visit PAHC's Balance sheet
Phibro Animal Health's Cost of Revenues TTM $ 1,004 Millions Visit PAHC's Income Statement
What are PAHC's Sales? Visit PAHC's Sales by Segment

Other Inventory Turnover Ratios
Phibro Animal Health's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
PAHC's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for PAHC's Competitors
Inventory Turnover Ratio for PAHC's Suppliers
Inventory Turnover Ratio for PAHC's Customers

You may also want to know
PAHC's Sales Growth Rates PAHC's Pe Price to earnings ratio PAHC's Receivables Turnover Ratio PAHC's Stock Quote
PAHC's Net Income Growth Rates PAHC's Ps Price to Sales ratio PAHC's Sales per Employee PAHC's Asset Turnover Ratio
PAHC's Net Margin PAHC's Pb Price to Book ratio PAHC's Financial Strength Ratios PAHC's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions
Nexgel Inc   3.49 $ 7.577  Millions$ 2  Millions
Lifeward ltd   3.47 $ 13.976  Millions$ 4  Millions
Bellevue Life Sciences Acquisition Corp  3.38 $ 1.215  Millions$ 0  Millions
10x Genomics Inc   3.29 $ 184.539  Millions$ 56  Millions
Maravai Lifesciences Holdings Inc   3.22 $ 135.038  Millions$ 42  Millions
Mettler toledo International Inc   3.18 $ 1,277.460  Millions$ 401  Millions
Bionexus Gene Lab Corp   3.15 $ 2.362  Millions$ 1  Millions
Mimedx Group Inc   3.07 $ 75.981  Millions$ 25  Millions
Msa Safety Inc  2.92 $ 1,021.036  Millions$ 350  Millions
Ligand Pharmaceuticals Incorporated  2.91 $ 32.387  Millions$ 11  Millions
Logicmark Inc  2.83 $ 3.881  Millions$ 1  Millions
Merck and Co Inc   2.79 $ 17,996.000  Millions$ 6,447  Millions
Inspiremd Inc   2.78 $ 8.847  Millions$ 3  Millions
Ani Pharmaceuticals Inc  2.69 $ 387.398  Millions$ 144  Millions
Biomerica Inc   2.59 $ 4.091  Millions$ 2  Millions
Evofem Biosciences Inc   2.58 $ 4.418  Millions$ 2  Millions

Date modified: 2026-08-29T04:46:46+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.